Second generation drug-eluting stents: a focus on safety and efficacy of current devices.

Francesco Spione, Salvatore Brugaletta

Expert review of cardiovascular therapy 2021 Feb

filter terms:

Introduction: Percutaneous coronary intervention (PCI) represents the most frequent procedure performed in medicine. Second generation drug eluting stents (DES) have been developed to reduce the rates of late and very late complications of first generation DES.Areas covered: To improve long-term efficacy and safety of patients undergoing PCI, second generation DES have been developed with novel stent platforms, biocompatible durable and biodegradable polymers and newer antiproliferative agents. In this review we provide an overview of second generation DES and their clinical trials, discussing safety and effectiveness of these devices, and outlining clinical indication for use.Expert commentary: Numerous clinical trials have demonstrated the safety and efficacy of second generation DES over the last decade. These devices represent the gold standard treatment in stable and acute coronary syndromes.

Citation

Francesco Spione, Salvatore Brugaletta. Second generation drug-eluting stents: a focus on safety and efficacy of current devices. Expert review of cardiovascular therapy. 2021 Feb;19(2):107-127